Private

eHealth Digital Media is a digital health company based in Swansea. The company have developed PocketMedic, a mobile application that contains a library of films to help patients manage their health conditions. Films are available for multiple diseases, including diabetes, lymphoedema, heart failure, COPD, exercise with lung disease, chronic pain, recovery from cancer, wellbeing, pressure ulcer prevention and end of life care.

DTR Medical is a medical device manufacturer that offers single-use surgical instruments. The company offers products in the areas of gynaecology, neurosurgical, ophthalmic, ENT max fax, general surgery, and orthopaedics.

CPR Global Tech is a digital company who have developed the CPR Guardian, a wearable smartwatch which can detect if a user has fallen and sets off an SOS alarm which can be sent to carers or family members.

CanSense is a Swansea University spin-out who are developing a blood-based assay for the non-invasive diagnosis of bowel cancer using artificial intelligence-based modelling.

Calon Cardio is a Swansea-based medical device company. The company have developed the Calon MiniVAD a miniature implantable blood pump for the treatment of patients with advanced chronic heart failure which is currently undergoing clinical testing required for regulatory approval.

Blue Sky Laser Technologies is a Swansea-based company who specialise in supplying laser technology. Blue Sky supply laser machines which can be used clinically to treat skin inflammation.

Biovici develop Point-of-Care diagnostic devices. The company also sell Graphene chips that can be used to produce real-time biosensors and chemical sensors.

Arcadia Pharmaceuticals is manufacture and supply unlicensed medicines (Specials) to the NHS, including Oral Liquids, Topical Preparations, External Liquids and Capsules. The company also sources and procures Special Obtains (an item that is difficult to source and generally not available from the mainline wholesalers).

Morvus Technology Limited is a privately owned pharmaceutical company who specialise in improving existing drugs which are off patent or have previously been abandoned. The company has three product lines, two of which have been licensed to other companies, with the other being developed by Gordian Pharma, a vehicle established by Morvus to develop MTL-004, a cytotoxic small molecule drug with the potential to help control cancer.

CellPath manufactures and supplies histology, pathology and cytology products, including equipment and consumables. In 2022, CellPath was acquired by US-based StatLab Medical Products